Direct answer. Cardiac rehabilitation is a structured recovery programme that combines assessment, suitable activity, education and support. It is offered after selected heart events or procedures and for conditions such as heart failure. Ask the treating team about referral and a plan matched to the actual diagnosis; an online routine cannot clear you for exercise.
- Rehabilitation includes more than exercise; medicines, education and emotional support still matter.
- A home programme can remain part of supervised clinical care.
- Assess suitability and report changing symptoms before progressing activity.
- Course length, referral routes and coverage vary by health system and individual need.
- A completion certificate, wearable score or improved fitness does not establish permanent cardiovascular safety.
Table of contents
- Evidence summary
- What it is
- How it works
- The evidence-based treatments
- Supplement and lifestyle evidence
- What works and what does not
- Risks and side effects
- Important interactions
- Who needs assessment
- Clinician-led use and follow-up
- Animal and in-vitro evidence
- Funding and source roles
- Frequently asked questions
- Sources and funding notes
Evidence summary
| Question | Evidence role | Interpretation / confidence |
|---|---|---|
| Who may benefit? | Current provider examples | Several diagnoses and procedures; individual eligibility and timing need assessment. |
| Home or centre? | Selected NICE recommendation | An accessible format with appropriate assessment and clinical support; not an unsupervised generic challenge. |
| How long? | NHS examples | A described course length is not a universal requirement or recovery deadline. |
| What outcomes are established here? | Focused evidence assessment | Converging attributed care guidance. No fully financially screened comparative effect size or vendor ranking was completed. |
Confidence is moderate to high in the basic care components and need for individual assessment. Comparative outcomes and local access require a separate review. This is an attributed care map, not a new comparative trial review. Confidence in a supplement replacing clinical care is insufficient in the eligible evidence assessed here. The full funding chains behind guideline drug and device trials have not been cleared.
What it is
Cardiac rehabilitation, often shortened to cardiac rehab, is a planned programme for recovery and longer-term care after selected cardiovascular problems. It connects the diagnosis, prescribed treatment, activity and support. A programme can include nursing, exercise specialists, dietary input and psychological care, rather than consist only of a treadmill session. CUH service example.
Rehab is different from an exercise stress test, a generic gym membership or a commercial supplement package. A diagnostic test asks a defined clinical question; rehabilitation supports a continuing plan. Ask which event or condition the referral addresses, what the goals are and who reviews progress.
The August2026 ESC framework connects preparation, hospital recovery, post-acute programmes and continuing care. Its adult cardiac and cardiotoxic-cancer scope excludes stroke, aortic aneurysm and peripheral arterial disease. Original scope.
How it works
An initial assessment considers the person’s condition, recovery and needs. The team can select practical activities and review progress as circumstances change. NICE’s heart-failure recommendation describes personalised exercise-based rehabilitation preceded by suitability assessment, with education and psychological support in an accessible setting. Indexed original recommendation1.11.1.
Rebuilding confidence and understanding can matter alongside physical performance. Learning what a medicine does, how to recognize deterioration and whom to contact gives the programme a purpose beyond recording exercise minutes. More exertion is not automatically better recovery. The team should explain the actual plan and what would cause it to change.
The evidence-based treatments
Provider programmes can support recovery after a heart attack, surgery, selected devices and heart failure, among other clinical situations. CUH also describes support for angina and spontaneous coronary artery dissection. These are examples from a specific service; they do not establish that every person with any heart diagnosis has identical eligibility or timing. Actual service scope.
After a heart attack, NHLBI describes supervised activity, education and counselling alongside ongoing medical treatment. Its older page’s US coverage example and driving timetable are not adopted as worldwide current rules. Discuss an appropriate local programme and unresolved access barriers with the care team. Selected recovery framework.
A plan should connect rehabilitation with the specialist follow-up already required by the diagnosis. Device, valve, inherited rhythm and congenital conditions can involve additional restrictions. Successful completion of a general course cannot replace those particular instructions. Ask who coordinates the different appointments and updates the activity plan when another clinician changes treatment.
Supplement and lifestyle evidence
Activity, food choices, smoking support and emotional care can be discussed in rehabilitation. They complement prescribed treatment. No supplement regimen has been independently established in this guide to replace the programme, dissolve coronary blockage or restore heart function. A product’s effect on one blood marker does not show that it replaces recovery care.
If appetite, cost, gastrointestinal symptoms, weight change or a restrictive diet makes eating difficult, raise the actual problem with the team. A dietitian can consider the diagnosis and treatment together. Do not infer from a generic heart-health slogan that every patient should use the same fluid restriction, salt substitute or calorie target.
Recovery after an arrest may also involve fear, memory or other health needs. NHLBI’s selected follow-up context supports discussing recovery and emotional concerns with the team. This is not a prediction of an individual survivor’s outcome or permission to resume an activity from another person’s account. Life-after-arrest context.
What works and what does not
A useful programme has a defined clinical connection, suitable assessment, realistic goals, a contact point and a way to review progress. Ask how sessions relate to daily activities that matter to you. Being able to shop, walk to transport or return to a specific job is a different question from reaching a marketing leaderboard.
The care sources describe benefits, but this article has not completed a systematic, financially screened review of the underlying rehabilitation trials. It reports no universal survival percentage, number-needed-to-treat or claim that a particular app is superior. The September2025 NICE methods document retains prior rehabilitation evidence; a wording update should not be presented as a new trial. Indexed original methods.
Home delivery can include clinical assessment and continuing support. A free video, paid tracker or remote class is not automatically equivalent to a clinically organized home programme. Compare the assessment, feedback, symptom plan and access to staff, rather than assume a screen makes care either adequate or inadequate.
The ESC cautions that trials comparing supervised home and centre programmes cannot establish identical rates of rare cardiovascular harm. Choose the setting through clinical assessment, rather than assume equal safety. Original uncertainty.
Risks and side effects
Exercise after a heart problem needs a suitable plan. NHLBI describes possible musculoskeletal injury and, rarely, serious rhythm problems within rehabilitation. This is one reason for assessment and support; it does not justify avoiding all appropriate activity. The actual condition and symptoms should determine the plan. Risk context.
New or worsening chest symptoms, major breathlessness, collapse or a severe deterioration require an urgent response. Do not continue a session to meet a target or wait for a routine rehabilitation appointment during an emergency. Follow the local emergency service and your clinical emergency plan. Current NHS emergency context.
For less acute changes, contact the team before the next exercise session. CUH’s preparation information asks about changes in symptoms, recent hospital care, illness, medicines and low blood glucose. Its detailed local rescheduling windows and rescue-drug timetable are not universal instructions here. Actual pre-assessment context.
Important interactions
Bring an up-to-date list of prescriptions and nonprescription products. Ask how the actual medicines affect the activity and symptom plan. Do not omit doses to make the exercise test harder or start a stimulant product to improve a session score. A rehabilitation appointment does not authorize an independent change in antiplatelet, rhythm, pressure or diabetes treatment.
The CUH assessment page tells patients to take prescribed medicines and bring relevant supplied rescue treatment and diabetes equipment. It also asks about musculoskeletal limitations. These are examples of individualized preparation; a hospital’s list cannot establish that every reader should use a particular medicine or device. Provider appointment information.
Tell the team when another prescriber changes treatment, a new product causes symptoms or your usual activity becomes harder. Different services may not automatically have the same medication list. The practical question is who has reconciled the current plan, not whether every medicine appears on an online heart-health list.
Who needs assessment
Suitability assessment should precede the programme. If you have not been assessed, or symptoms, illness or injuries have changed, CUH’s home-exercise resource advises contacting the team before starting. A past assessment is not permanent clearance after a new clinical event. Home-resource safety condition.
This adult care guide does not prescribe paediatric exercise, pregnancy activity, competitive sport or a return to heavy work. Those decisions can depend on a particular condition and specialist assessment. Clarify what restrictions apply now, when they are reviewed and what activity remains appropriate in the meantime.
ESC calls for clinical risk and exercise assessment before centre or supervised home training. Acute unstable illness can prevent exercise. Education, nutrition, psychological support and treatment review can still start while exercise is deferred. Selected safety framework.
Clinician-led use and follow-up
There is no rehabilitation supplement dose or universal exercise prescription here. Confirm the referral, appointment format, preparation, activity plan and contact details. NHS recovery information describes local group, online and home options, but the route and programme length vary; the example course duration is not a personal deadline. NHS access examples.
If transport, work, caring duties, language, disability, cost or internet access prevents attendance, tell the team and ask what alternatives are actually available. Request an explanation of any programme fee and coverage before booking. This guide has not verified current eligibility or funding in the reader’s country.
Before the course ends, ask what happens next: who reviews treatment, which activities you should continue, how progress is assessed and which symptoms require contact. Missing a session should lead to a practical discussion, not compensating with a much harder workout. A home plan needs a named clinical contact and a clear response to changed symptoms.
Animal and in-vitro evidence
Changes in muscle conditioning, stress physiology or a laboratory marker can help explain a plausible mechanism, but cannot establish that a retail exercise programme, wearable or supplement prevents a human cardiovascular event. Animal and cell results do not specify a safe personal activity dose. Vendor outcome claims require separate clinical, methods and funding review.
Funding and source roles
Who paid for the evidence?
Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.
View 12 more funding disclosures
This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.
Financial interests include exercise and monitoring equipment, remote platforms, clinical rehabilitation, paid training and supplement sales. CUH’s actual accounts distinguish public patient-care funding from private, research, training and other income. This guide explains attributed care and practical questions; it does not rank services, infer all trials are independent from public branding or establish a commercial programme’s superiority.
Rehabilitation is a care approach; individual services, devices and training products have their own owners and commercial routes. Providers, pharmaceutical companies, device manufacturers and supplement sellers can receive revenue from different care choices. That is an incentive analysis, not an allegation of improper care. This source set is concentrated in the United States and United Kingdom. Retail manufacturing origin, batch quality and the complete financial chain of original treatment trials were not established.
Funding tier measures proximity to the subject; the credibility grade evaluates transparency and accuracy incentives. Provisional classifications are not a declaration that every conflict has been excluded. Public financial support for an educational page does not turn commercially supported underlying trials into independent efficacy evidence.
| Source | Funding / backers | Country / jurisdiction | Independence / credibility / gaps | Role in this article |
|---|---|---|---|---|
| ESC original cardiac rehabilitation guideline, August2026 | The August2026 original states ESC funded guideline development without healthcare-industry involvement. Full separate author declarations and underlying trial finances were not cleared. ESC income routes include industry partnerships. | France; ESC association, multinational European clinical panel. | Tier2 institutional route provisional / C for incomplete author and study financial clearance. Selected assessment and scope guidance; no independent comparative effect verdict. | Selected scope, assessment and exercise-safety context |
| ESC current funding model | ESC reports membership, congress/event, publishing, education/accreditation income and life-science/medtech partnerships. Current income mix cannot identify individual trial sponsors. Full2026 donor allocations remain unresolved. | France; European Society of Cardiology association. | Tier3 institutional financial self-disclosure / B provisional. Supports financial provenance, not a blanket independence claim. | Institutional income and industry routes |
| NHS coronary recovery, January2024 | DHSC-funded national NHS website under its own no-corporate-advertising/sponsorship policy. Actual January17,2024 review is within the January2027 displayed review period. Page allocation, named contributors and all rehabilitation-study finances unresolved. | United Kingdom; NHS England national education. | Tier1 education provisional / B provisional for practical care context. No independently screened effect size or universal referral/timetable rule. | Programme components and access examples |
| CUH current cardiac rehabilitation service | Actual current CUH provider original, including live2026 service/pre-assessment information; displayed print timestamp is not a clinical review date. Full own2025/26 accounts show public patient-care and private/overseas, research, training and other income. Leaflet budget, named authors and underlying trials untraced. National NHS website policy cannot be transferred to this hospital. | United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge, England. | Tier2 mixed institutional provider route provisional / C for incomplete source-level financial clearance. Practical service examples only; paid-service superiority and universal timetable claims excluded. | Multidisciplinary care and delivery options |
| CUH current rehabilitation pre-assessment | Actual current CUH provider original, including live2026 service/pre-assessment information; displayed print timestamp is not a clinical review date. Full own2025/26 accounts show public patient-care and private/overseas, research, training and other income. Leaflet budget, named authors and underlying trials untraced. National NHS website policy cannot be transferred to this hospital. | United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge, England. | Tier2 mixed institutional provider route provisional / C for incomplete source-level financial clearance. Practical service examples only; paid-service superiority and universal timetable claims excluded. | Appointment preparation, symptom reporting and medicine context |
| CUH original home-exercise resource | Actual current CUH provider original, including live2026 service/pre-assessment information; displayed print timestamp is not a clinical review date. Full own2025/26 accounts show public patient-care and private/overseas, research, training and other income. Leaflet budget, named authors and underlying trials untraced. National NHS website policy cannot be transferred to this hospital. | United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge, England. | Tier2 mixed institutional provider route provisional / C for incomplete source-level financial clearance. Practical service examples only; paid-service superiority and universal timetable claims excluded. | Assessment before starting or resuming a supplied programme |
| NICE NG106, September2025 indexed original | NICE mainly receives DHSC grant-in-aid with NHS England, appraisal/advice and research income; actual 2025/26 accounts. September2025 recommendation1.11.1 read from the indexed original; direct full retrieval403. Committee and underlying rehabilitation-trial financial chains remain unresolved. | United Kingdom; NICE public-body and English guidance context. | Tier2 institutional route provisional / C for incomplete financial clearance and full access. Selected attributed recommendation, not a cleared comparative outcome verdict. | Personalised assessed exercise-based rehabilitation with education and psychological support |
| NICE NG106 September2025 methods, indexed original | Same public-body route as linked actual accounts. Indexed original September2025 methods says cardiac-rehabilitation wording was amended for consistency while evidence comes from prior guideline versions; full direct PDF blocked. No complete author, older trial or supplier audit. | United Kingdom; NICE English guideline-development jurisdiction. | Tier2 institutional route provisional / C for access and untraced study finances. Methods/date context only; not a new2025 rehabilitation trial. | Prior evidence retained; wording update is not a fresh rehabilitation trial |
| NHLBI heart-attack recovery, March2022 | NHLBI federal education, March24,2022; appropriations and permitted gifts. Actual institutional route. Full contributor and original rehabilitation-trial finances unresolved. US insurance-session and driving statements are not current worldwide rules; no automatic medicine reduction adopted. | United States; NIH/NHLBI, Bethesda. | Tier1 educational route provisional / C for age and simplified local details. Selected supervised-care and support framework, without numerical benefit promises. | Supervised recovery, barriers and ongoing treatment |
| NHLBI life after arrest, May2022 | NHLBI federal education, May19,2022; appropriations and permitted gifts. Contributor, device and rehabilitation-trial finance unresolved. Dated unrelated sickle-cell editorial text and personal activity/device instructions not adopted. | United States; NIH/NHLBI, Bethesda. | Tier1 educational route provisional / C for date and editorial anomaly. Selected survivor follow-up and emotional-support context only. | Selected follow-up and emotional support |
| NHS heart attack, March2026 | DHSC-funded national NHS website under its own funding policy. Actual March2026 current heart-attack page; complete contributors and supporting-treatment trial finance unresolved. | United Kingdom; NHS England public education. | Tier1 education provisional / B provisional for emergency/recovery context. Not a personal exercise, driving or medicine plan. | Recovery and urgent symptoms |
| CUH original annual accounts2025/26 | Original197-page 2025/26 accounts retrieved. PDF pages169–170 (printed164–165) identify NHS/ICB patient care, private/overseas patients, research, training, capital donations, leases and other services. These are aggregate routes, not rehabilitation-page allocations or a complete commercial research-backers ledger. | United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge, England. | Tier3 statutory financial self-disclosure / B provisional. Audited aggregate reporting supports provenance, not individual author or trial clearance. | Institutional financial route; not programme efficacy |
| NICE original annual accounts2025/26 | Original 2025/26 accounts: mainly DHSC grant-in-aid, with NHS England funding, income-generating appraisal/advice activity and research. No complete NG136 committee and trial chain follows from aggregate accounts. | United Kingdom; NICE public body. | Tier 3 financial self-disclosure / B provisional. Statutory reporting supports provenance; page allocation and individual conflicts unresolved. | Institutional funding route |
| NHLBI institutional budget and funding | US federal appropriations; NHLBI also has a permitted gift fund. Institutional funding. No page-level commercial sponsor identified; full author and underlying trial finances untraced. | United States; NIH/NHLBI, Bethesda, federal jurisdiction. | Tier 3 for institutional self-disclosure; B provisional. Official financial reporting with legal accountability; selective presentation and unidentified gift donors remain possible. | Financial provenance only |
| NHS website content and funding policy | DHSC-funded NHS website; policy states no corporate sponsorship or advertising. Funding policy. Page-specific authors and complete underlying study funding unresolved. | United Kingdom; England public-information service. Local health systems differ. | Tier 3 for institutional self-disclosure; B provisional. Direct funding and editorial policy, with public accountability; actual individual declarations and implementation were not audited. | Financial and editorial self-disclosure only; policy reviewed October 2022 |
Frequently asked questions
Is cardiac rehab just exercise?
No. It can include assessment, education, dietary input and emotional support.
Can I do it at home?
Some programmes use home or remote delivery with clinical support. Ask whether the offered format matches your needs.
Does everyone need the same number of sessions?
No universal duration is established here; the diagnosis, goals and local service matter.
Can I stop medicines if I feel fitter?
No. Changes need the treating clinician’s advice.
Does finishing the course clear competitive sport or driving?
No. Ask about the specific condition, activity and local rules.
What if I become unwell during a session?
Stop and alert the team; emergency symptoms need emergency help rather than waiting for routine follow-up.
Sources and funding notes
- ESC original cardiac rehabilitation guideline, August2026 — Selected scope, assessment and exercise-safety context.
- ESC current funding model — Institutional income and industry routes.
- NHS coronary recovery, January2024 — Programme components and access examples.
- CUH current cardiac rehabilitation service — Multidisciplinary care and delivery options.
- CUH current rehabilitation pre-assessment — Appointment preparation, symptom reporting and medicine context.
- CUH original home-exercise resource — Assessment before starting or resuming a supplied programme.
- NICE NG106, September2025 indexed original — Personalised assessed exercise-based rehabilitation with education and psychological support.
- NICE NG106 September2025 methods, indexed original — Prior evidence retained; wording update is not a fresh rehabilitation trial.
- NHLBI heart-attack recovery, March2022 — Supervised recovery, barriers and ongoing treatment.
- NHLBI life after arrest, May2022 — Selected follow-up and emotional support.
- NHS heart attack, March2026 — Recovery and urgent symptoms.
- CUH original annual accounts2025/26 — Institutional financial route; not programme efficacy.
- NICE original annual accounts2025/26 — Institutional funding route.
- NHLBI budget and legislative information — institutional public funding and gift-fund context; not a page-level donor audit.
NHS, NHLBI and CUH clinical originals were opened, including CUH’s current2026 preparation information. CUH’s full197-page2025/26 accounts were retrieved and financial tables checked on PDF pages169–170. Current NICE recommendations and methods were read from indexed originals; full direct access was blocked. NICE’s actual2025/26 financial report had been opened. No complete original rehabilitation-trial funding audit or service-outcome ranking was completed. Education, financial self-disclosure and therapeutic outcome evidence are separate roles. No manufacturer-supported outcome study establishes the independent verdict in this guide. A complete systematic review, author-by-author financial audit and current local prescribing comparison were not completed. These limitations constrain the conclusion; they do not prove that clinical treatment is ineffective.
Last reviewed: October 4, 2026. Educational information; diagnosis, prescribing and emergency decisions belong with qualified professionals and local emergency services.
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.
One daily research roundup
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.
